Voyager Therapeutics Inc’s recent filing unveils that its President and CEO Sandrock Alfred unloaded Company’s shares for reported $97226.0 on Feb 21 ’24. In the deal valued at $7.46 per share,13,033 shares were sold. As a result of this transaction, Sandrock Alfred now holds 334,954 shares worth roughly $3.36 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Swartz Robin sold 3,966 shares, generating $29,547 in total proceeds. Upon selling the shares at $7.45, the Chief Operating Officer now owns 118,361 shares.
Before that, PFREUNDSCHUH PETER P. sold 3,764 shares. Voyager Therapeutics Inc shares valued at $28,079 were divested by the Chief Financial Officer at a price of $7.46 per share. As a result of the transaction, PFREUNDSCHUH PETER P. now holds 175,669 shares, worth roughly $1.76 million.
Guggenheim initiated its Voyager Therapeutics Inc [VYGR] rating to a Buy in a research note published on March 26, 2024; the price target was $22. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. Citigroup began covering VYGR with “Buy” recommendation on March 07, 2024. Wells Fargo revised its rating on January 02, 2024. It rated VYGR as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of VYGR
On Tuesday, Voyager Therapeutics Inc [NASDAQ:VYGR] saw its stock jump 8.21% to $10.02. Over the last five days, the stock has lost -0.40%. Voyager Therapeutics Inc shares have risen nearly 18.72% since the year began. Nevertheless, the stocks have risen 35.96% over the past one year. While a 52-week high of $14.34 was reached on 01/02/24, a 52-week low of $6.06 was recorded on 01/17/24. SMA at 50 days reached $8.29, while 200 days put it at $8.58. A total of 0.88 million shares were traded, compared to the trading of 0.48 million shares in the previous session.
Levels Of Support And Resistance For VYGR Stock
The 24-hour chart illustrates a support level at 9.70, which if violated will result in even more drops to 9.38. On the upside, there is a resistance level at 10.27. A further resistance level may holdings at 10.51. The Relative Strength Index (RSI) on the 14-day chart is 60.61, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.02, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 31.79%. Stochastics %K at 34.10% indicates the stock is a holding.
How much short interest is there in Voyager Therapeutics Inc?
A steep rise in short interest was recorded in Voyager Therapeutics Inc stocks on Feb 29, 2024, growing by 0.29 million shares to a total of 2.26 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 1.97 million shares. There was a rise of 12.83%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 4.98% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.55.
The most recent change occurred on May 10, 2023 when Truist began covering the stock and recommended ‘”a Buy”‘ rating along with a $18 price target.
